C/EBPβ mediates anti-proliferative effects of 1,25(OH)2D on differentiated thyroid carcinoma cells

in Endocrine-Related Cancer
Authors:
Feng Xu National Clinical Research Center for Metabolic Diseases, Hunan Provincial Key Laboratory of Metabolic Bone Diseases, and Department of Metabolism and Endocrinology, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China

Search for other papers by Feng Xu in
Current site
Google Scholar
PubMed Close
,
Yali Ling National Clinical Research Center for Metabolic Diseases, Hunan Provincial Key Laboratory of Metabolic Bone Diseases, and Department of Metabolism and Endocrinology, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China

Search for other papers by Yali Ling in
Current site
Google Scholar
PubMed Close
,
Jingjing Yuan National Clinical Research Center for Metabolic Diseases, Hunan Provincial Key Laboratory of Metabolic Bone Diseases, and Department of Metabolism and Endocrinology, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China

Search for other papers by Jingjing Yuan in
Current site
Google Scholar
PubMed Close
,
Qin Zeng National Clinical Research Center for Metabolic Diseases, Hunan Provincial Key Laboratory of Metabolic Bone Diseases, and Department of Metabolism and Endocrinology, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China

Search for other papers by Qin Zeng in
Current site
Google Scholar
PubMed Close
,
Lusha Li National Clinical Research Center for Metabolic Diseases, Hunan Provincial Key Laboratory of Metabolic Bone Diseases, and Department of Metabolism and Endocrinology, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China

Search for other papers by Lusha Li in
Current site
Google Scholar
PubMed Close
,
Dexing Dai National Clinical Research Center for Metabolic Diseases, Hunan Provincial Key Laboratory of Metabolic Bone Diseases, and Department of Metabolism and Endocrinology, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China

Search for other papers by Dexing Dai in
Current site
Google Scholar
PubMed Close
,
Xuedi Xia National Clinical Research Center for Metabolic Diseases, Hunan Provincial Key Laboratory of Metabolic Bone Diseases, and Department of Metabolism and Endocrinology, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China

Search for other papers by Xuedi Xia in
Current site
Google Scholar
PubMed Close
,
Ruoman Sun National Clinical Research Center for Metabolic Diseases, Hunan Provincial Key Laboratory of Metabolic Bone Diseases, and Department of Metabolism and Endocrinology, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China

Search for other papers by Ruoman Sun in
Current site
Google Scholar
PubMed Close
,
Ran Zhang Department of Medical Laboratory, Hunan Normal University School of Medicine, Changsha, Hunan, China

Search for other papers by Ran Zhang in
Current site
Google Scholar
PubMed Close
, and
Zhongjian Xie National Clinical Research Center for Metabolic Diseases, Hunan Provincial Key Laboratory of Metabolic Bone Diseases, and Department of Metabolism and Endocrinology, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China

Search for other papers by Zhongjian Xie in
Current site
Google Scholar
PubMed Close
https://orcid.org/0000-0002-1601-1156

Correspondence should be addressed to Z Xie: zhongjian.xie@csu.edu.cn
DOI:
https://doi.org/10.1530/ERC-21-0309
Volume/Issue:
Volume 29: Issue 6
Article Type:
Research Article
Page Range:
321–334
Online Publication Date:
09 May 2022
Copyright:
© Society for Endocrinology 2022
Restricted access
Rent on DeepDyve

Sign up for journal news

Differentiated thyroid carcinoma (DTC) is the most common endocrine malignancy and highly expresses the receptor for 1,25-dihydroxyvitamin D (1,25(OH)2D). However, it is unclear whether 1,25(OH)2D regulates DTC proliferation and differentiation. Here, we found that 1,25(OH)2D3 inhibited proliferation but not differentiation of the DTC cells. Notably, CYP27B1was elevated in DTC cells and 25-hydroxyvitamin D3 (25(OH)D3) reduced DTC cell proliferation. Knockdown of VDR did not affect the anti-proliferative effects of 1,25(OH)2D3. However, knockdown of CCAAT enhancer-binding protein β (C/EBPβ)abolished 1,25(OH)2D3-suppressed DTC cell proliferation. In addition, 1,25(OH)2D3 induced phosphorylation and translocation of C/EBPβto the nucleus from the cytoplasm. However, inhibition of p38 mitogen-activated protein kinases (MAPK) abrogated 1,25(OH)2D3-induced phosphorylation and nuclear translocation of C/EBPβas well as 1,25(OH)2D3-suppressed DTC cell proliferation. Knockdown of C/EBPβreduced the expression of Notch3. Knockdown of Notch3 blocked 1,25(OH)2D3-suppressed DTC cell proliferation. In the DTC cell-derived xenograft SCID mouse, knockdown of C/EBPβmarkedly increased tumor growth and proliferation and decreased apoptosis. In DTC patients, C/EBPβwas predominantly located in the cytoplasm of DTC cells in the tumor tissue when compared with adjacent non-cancerous tissue in which C/EBPβis located in the nucleus. In conclusion, C/EBPβstimulated Notch3signaling via the p38 MAPK-dependent pathway mediates the inhibitory effect of 1,25(OH)2D on DTC cell proliferation.

Supplementary Materials

Endocrine-Related Cancer is committed to supporting researchers in demonstrating the impact of their articles published in the journal.

The two types of article metrics we measure are (i) more traditional full-text views and pdf downloads, and (ii) Altmetric data, which shows the wider impact of articles in a range of non-traditional sources, such as social media.

More information is on the Reasons to publish page.

Sept 2018 onwards Past Year Past 30 Days
Full Text Views 397 14 0
PDF Downloads 189 13 0

 

  • Collapse
  • Expand
Print ISSN:
1351-0088
Online ISSN:
1479-6821
Copyright:
© Society for Endocrinology 2022
Page(s):
14
Received Date:
18 Mar 2022
Accepted Date:
28 Mar 2022
Print Publication Date:
01 Jun 2022
Online Publication Date:
09 May 2022
Keywords:
CCAAT enhancer binding protein β; 1,25-dihydroxyvitaminD; Notch3; differentiated thyroid carcinoma; proliferation

  • Albi E, Cataldi S, Ferri I, Sidoni A, Traina G, Fettucciari K, Ambesi-Impiombato FS, Lazzarini A, Curcio F & Ceccarini MR et al.2018 VDR independent induction of acid-sphingomyelinase by 1,23(OH) D in gastric cancer cells: impact on apoptosis and cell morphology. Biochimie 146 35–42. (https://doi.org/10.1016/j.biochi.2017.11.011)

    • PubMed
    • Search Google Scholar
    • Export Citation

  • Balla B, Tobiás B, Kósa JP, Podani J, Horváth P, Nagy Z, Horányi J, Járay B, Székely E & Krenács L et al.2015 Vitamin D-neutralizing CYP24A1 expression, oncogenic mutation states and histological findings of human papillary thyroid cancer. Journal of Endocrinological Investigation 38 313–321. (https://doi.org/10.1007/s40618-014-0165-7)

    • PubMed
    • Search Google Scholar
    • Export Citation

  • Boström P, Mann N, Wu J, Quintero PA, Plovie ER, Panáková D, Gupta RK, Xiao C, MacRae CA & Rosenzweig A et al.2010 C/EBPβ controls exercise-induced cardiac growth and protects against pathological cardiac remodeling. Cell 143 1072–1083. (https://doi.org/10.1016/j.cell.2010.11.036)

    • PubMed
    • Search Google Scholar
    • Export Citation

  • Boyan BD, Chen J & Schwartz Z 2012 Mechanism of Pdia3-dependent 1α,25-dihydroxy vitamin D3 signaling in musculoskeletal cells. Steroids 77 892–896. (https://doi.org/10.1016/j.steroids.2012.04.018)

    • PubMed
    • Search Google Scholar
    • Export Citation

  • Buck M, Zhang L, Halasz NA, Hunter T & Chojkier M 2001 Nuclear export of phosphorylated C/EBPbeta mediates the inhibition of albumin expression by TNF-alpha. EMBO Journal 20 6712–6723. (https://doi.org/10.1093/emboj/20.23.6712)

    • PubMed
    • Search Google Scholar
    • Export Citation

  • Chinery R, Brockman JA, Dransfield DT & Coffey RJ 1997 Antioxidant-induced nuclear translocation of CCAAT/enhancer-binding protein beta. A critical role for protein kinase A-mediated phosphorylation of Ser299. Journal of Biological Chemistry 272 30356–30361. (https://doi.org/10.1074/jbc.272.48.30356)

    • PubMed
    • Search Google Scholar
    • Export Citation

  • Choi JY, Yi JW, Lee JH, Song RY, Yu H, Kwon H, Chai YJ, Kim SJ & Lee KE 2017 VDR mRNA overexpression is associated with worse prognostic factors in papillary thyroid carcinoma. Endocrine Connections 6 172–178. (https://doi.org/10.1530/EC-17-0001)

    • PubMed
    • Search Google Scholar
    • Export Citation

  • Clinckspoor I, Verlinden L, Overbergh L, Korch C, Bouillon R, Mathieu C, Verstuyf A & Decallonne B 2011 1,25-Dihydroxyvitamin D3 and a superagonistic analog in combination with paclitaxel or suberoylanilide hydroxamic acid have potent antiproliferative effects on anaplastic thyroid cancer. Journal of Steroid Biochemistry and Molecular Biology 124 1–9. (https://doi.org/10.1016/j.jsbmb.2010.12.008)

    • PubMed
    • Search Google Scholar
    • Export Citation

  • Clinckspoor I, Gérard AC, Van Sande J, Many MC, Verlinden L, Bouillon R, Carmeliet G, Mathieu C, Verstuyf A & Decallonne B 2012a The vitamin D receptor in thyroid development and function. European Thyroid Journal 1 168–175. (https://doi.org/10.1159/000342363)

    • PubMed
    • Search Google Scholar
    • Export Citation

  • Clinckspoor I, Hauben E, Verlinden L, Van den Bruel A, Vanwalleghem L, Vander Poorten V, Delaere P, Mathieu C, Verstuyf A & Decallonne B 2012b Altered expression of key players in vitamin D metabolism and signaling in malignant and benign thyroid tumors. Journal of Histochemistry and Cytochemistry 60 502–511. (https://doi.org/10.1369/0022155412447296)

    • PubMed
    • Search Google Scholar
    • Export Citation

  • Deeb KK, Trump DL & Johnson CS 2007 Vitamin D signalling pathways in cancer: potential for anticancer therapeutics. Nature Reviews: Cancer 7 684–700. (https://doi.org/10.1038/nrc2196)

    • PubMed
    • Search Google Scholar
    • Export Citation

  • Doroudi M, Schwartz Z & Boyan BD 2015 Membrane-mediated actions of 1,25-dihydroxy vitamin D3: a review of the roles of phospholipase A2 activating protein and Ca(2+)/calmodulin-dependent protein kinase II. Journal of Steroid Biochemistry and Molecular Biology 147 81–84. (https://doi.org/10.1016/j.jsbmb.2014.11.002)

    • PubMed
    • Search Google Scholar
    • Export Citation

  • Horas K, Zheng Y, Fong-Yee C, Macfarlane E, Manibo J, Chen Y, Qiao J, Gao M, Haydar N & McDonald MM et al.2019 Loss of the vitamin D receptor in human breast cancer cells promotes epithelial to mesenchymal cell transition and skeletal colonization. Journal of Bone and Mineral Research 34 1721–1732. (https://doi.org/10.1002/jbmr.3744)

    • PubMed
    • Search Google Scholar
    • Export Citation

  • Hu MJ, Zhang Q, Liang L, Wang SY, Zheng XC, Zhou MM, Yang YW, Zhong Q & Huang F 2018a Association between vitamin D deficiency and risk of thyroid cancer: a case-control study and a meta-analysis. Journal of Endocrinological Investigation 41 1199–1210. (https://doi.org/10.1007/s40618-018-0853-9)

    • PubMed
    • Search Google Scholar
    • Export Citation

  • Hu Z, Cao X, Fang Y, Liu G, Xie C, Qian K, Lei X, Cao Z, Du H & Cheng X et al.2018b Transient receptor potential vanilloid-type 2 targeting on stemness in liver cancer. Biomedicine and Pharmacotherapy 105 697–706. (https://doi.org/10.1016/j.biopha.2018.06.029)

    • PubMed
    • Search Google Scholar
    • Export Citation

  • Laney N, Meza J, Lyden E, Erickson J, Treude K & Goldner W 2010 The prevalence of vitamin D deficiency is similar between thyroid nodule and thyroid cancer patients. International Journal of Endocrinology 2010 805716. (https://doi.org/10.1155/2010/805716)

    • PubMed
    • Search Google Scholar
    • Export Citation

  • Li W, Tanikawa T, Kryczek I, Xia H, Li G, Wu K, Wei S, Zhao L, Vatan L & Wen B et al.2018 Aerobic glycolysis controls myeloid-derived suppressor cells and tumor immunity via a specific CEBPB isoform in triple-negative breast cancer. Cell Metabolism 28 87 .e6–103.e6. (https://doi.org/10.1016/j.cmet.2018.04.022)

    • PubMed
    • Search Google Scholar
    • Export Citation

  • Li L, Ji S, Shrestha C, Jiang Y, Liao L, Xu F, Liu Z, Bikle DD & Xie Z 2020 p120-catenin suppresses proliferation and tumor growth of oral squamous cell carcinoma via inhibiting nuclear phospholipase C-γ1 signaling. Journal of Cellular Physiology 235 9399–9413. (https://doi.org/10.1002/jcp.29744)

    • PubMed
    • Search Google Scholar
    • Export Citation

  • Lim H, Devesa SS, Sosa JA, Check D & Kitahara CM 2017 Trends in thyroid cancer incidence and mortality in the United States, 1974–2013. JAMA 317 1338–1348. (https://doi.org/10.1001/jama.2017.2719)

    • PubMed
    • Search Google Scholar
    • Export Citation

  • Lin CC, Tsai YL, Huang MT, Lu YP, Ho CT, Tseng SF & Teng SC 2006 Inhibition of estradiol-induced mammary proliferation by dibenzoylmethane through the E2-ER-ERE-dependent pathway. Carcinogenesis 27 131–136. (https://doi.org/10.1093/carcin/bgi199)

    • PubMed
    • Search Google Scholar
    • Export Citation

  • Ling Y, Xu F, Xia X, Dai D, Sun R & Xie Z 2022 Vitamin D receptor regulates proliferation and differentiation of thyroid carcinoma via the E-cadherin-β-catenin complex. Journal of Molecular Endocrinology 68 137–151. (https://doi.org/10.1530/JME-21-0167)

    • PubMed
    • Search Google Scholar
    • Export Citation

  • Marcinkowska E, Garay E, Gocek E, Chrobak A, Wang X & Studzinski GP 2006 Regulation of C/EBPbeta isoforms by MAPK pathways in HL60 cells induced to differentiate by 1,25-dihydroxyvitamin D3. Experimental Cell Research 312 2054–2065. (https://doi.org/10.1016/j.yexcr.2006.03.003)

    • PubMed
    • Search Google Scholar
    • Export Citation

  • Niehrs C & Calkhoven CF 2020 Emerging role of C/EBPβ and epigenetic DNA methylation in ageing. Trends in Genetics 36 71–80. (https://doi.org/10.1016/j.tig.2019.11.005)

    • PubMed
    • Search Google Scholar
    • Export Citation

  • Panda DK, Miao D, Tremblay ML, Sirois J, Farookhi R, Hendy GN & Goltzman D 2001 Targeted ablation of the 25-hydroxyvitamin D 1alpha-hydroxylase enzyme: evidence for skeletal, reproductive, and immune dysfunction. PNAS 98 7498–7503. (https://doi.org/10.1073/pnas.131029498)

    • PubMed
    • Search Google Scholar
    • Export Citation

  • Peña C, García JM, Silva J, García V, Rodríguez R, Alonso I, Millán I, Salas C, de Herreros AG & Muñoz A et al.2005 E-cadherin and vitamin D receptor regulation by SNAIL and ZEB1 in colon cancer: clinicopathological correlations. Human Molecular Genetics 14 3361–3370. (https://doi.org/10.1093/hmg/ddi366)

    • PubMed
    • Search Google Scholar
    • Export Citation

  • Pomérance M, Mockey M, Young J, Quillard J & Blondeau JP 2005 Expression, hormonal regulation, and subcellular localization of CCAAT/enhancer-binding protein-beta in rat and human thyrocytes. Thyroid 15 197–204. (https://doi.org/10.1089/thy.2005.15.197)

    • PubMed
    • Search Google Scholar
    • Export Citation

  • Roehlen N, Doering C, Hansmann ML, Gruenwald F, Vorlaender C, Bechstein WO, Holzer K, Badenhoop K & Penna-Martinez M 2018 Vitamin D, FOXO3a, and sirtuin1 in Hashimoto’s thyroiditis and differentiated thyroid cancer. Frontiers in Endocrinology 9 527. (https://doi.org/10.3389/fendo.2018.00527)

    • PubMed
    • Search Google Scholar
    • Export Citation

  • Stepien T, Krupinski R, Sopinski J, Kuzdak K, Komorowski J, Lawnicka H & Stepien H 2010 Decreased 1-25 dihydroxyvitamin D3 concentration in peripheral blood serum of patients with thyroid cancer. Archives of Medical Research 41 190–194. (https://doi.org/10.1016/j.arcmed.2010.04.004)

    • PubMed
    • Search Google Scholar
    • Export Citation

  • Wagner EF & Nebreda AR 2009 Signal integration by JNK and p38 MAPK pathways in cancer development. Nature Reviews: Cancer 9 537–549. (https://doi.org/10.1038/nrc2694)

    • PubMed
    • Search Google Scholar
    • Export Citation

  • Wang SH, Koenig RJ, Giordano TJ, Myc A, Thompson NW & Baker JR 1999 1Alpha,25-dihydroxyvitamin D3 up-regulates Bcl-2 expression and protects normal human thyrocytes from programmed cell death. Endocrinology 140 1649–1656. (https://doi.org/10.1210/endo.140.4.6659)

    • PubMed
    • Search Google Scholar
    • Export Citation

  • Wei ZL, Gao AB, Wang Q, Lou XE, Zhao J & Lu QJ 2019 MicroRNA-221 promotes papillary thyroid carcinoma cell migration and invasion via targeting RECK and regulating epithelial-mesenchymal transition. OncoTargets and Therapy 12 2323–2333. (https://doi.org/10.2147/OTT.S190364)

    • PubMed
    • Search Google Scholar
    • Export Citation

  • Wu W, Fan H, Jiang Y, Liao L, Li L, Zhao J, Zhang H, Shrestha C & Xie Z 2018 Regulation of 25-hydroxyvitamin D-1-hydroxylase and 24-hydroxylase in keratinocytes by PTH and FGF23. Experimental Dermatology 27 1201–1209. (https://doi.org/10.1111/exd.13760)

    • PubMed
    • Search Google Scholar
    • Export Citation

  • Xie Z, Yuan Y, Jiang Y, Shrestha C, Chen Y, Liao L, Ji S, Deng X, Liao E & Bikle DD 2017 p120-Catenin is required for dietary calcium suppression of oral carcinogenesis in mice. Journal of Cellular Physiology 232 1360–1367. (https://doi.org/10.1002/jcp.25620)

    • PubMed
    • Search Google Scholar
    • Export Citation

  • Xie Z, Tang Y, Man MQ, Shrestha C & Bikle DD 2018 p120-catenin is required for regulating epidermal proliferation, differentiation, and barrier function. Journal of Cellular Physiology 234 427–432. (https://doi.org/10.1002/jcp.26535)

    • PubMed
    • Search Google Scholar
    • Export Citation

  • Yang J, Horton JR, Wang D, Ren R, Li J, Sun D, Huang Y, Zhang X, Blumenthal RM & Cheng X 2019 Structural basis for effects of CpA modifications on C/EBPβ binding of DNA. Nucleic Acids Research 47 1774–1785. (https://doi.org/10.1093/nar/gky1264)

    • PubMed
    • Search Google Scholar
    • Export Citation

  • Zhang L, Gaskins K, Yu Z, Xiong Y, Merino MJ & Kebebew E 2014 An in vivo mouse model of metastatic human thyroid cancer. Thyroid 24 695–704. (https://doi.org/10.1089/thy.2013.0149)

    • PubMed
    • Search Google Scholar
    • Export Citation

  • Zhang T, Zhang H, He L, Wang Z, Dong W, Sun W & Zhang P 2018 Potential use of 1-25-dihydroxyvitamin D in the diagnosis and treatment of papillary thyroid cancer. Medical Science Monitor 24 1614–1623. (https://doi.org/10.12659/msm.909544)

    • PubMed
    • Search Google Scholar
    • Export Citation

  • Zhao J, Wang H, Zhang Z, Zhou X, Yao J, Zhang R, Liao L & Dong J 2019 Vitamin D deficiency as a risk factor for thyroid cancer: a meta-analysis of case-control studies. Nutrition 57 5–11. (https://doi.org/10.1016/j.nut.2018.04.015)

    • PubMed
    • Search Google Scholar
    • Export Citation

  • Zheng R, Wang X & Studzinski GP 2015 1,25-Dihydroxyvitamin D3 induces monocytic differentiation of human myeloid leukemia cells by regulating C/EBPβ expression through MEF2C. Journal of Steroid Biochemistry and Molecular Biology 148 132–137. (https://doi.org/10.1016/j.jsbmb.2014.11.016)

    • PubMed
    • Search Google Scholar
    • Export Citation